title: High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.
abstract: The profound hypogonadism that occurs with androgen deprivation therapy (ADT) for prostate cancer (PCa) results in complications such as diabetes and metabolic syndrome that predispose to cardiovascular disease. Because phytoestrogens have been associated with an improvement in metabolic parameters, we evaluated their role in men undergoing ADT. Our objective was to evaluate the effects of high-dose isoflavones on metabolic and inflammatory parameters in men undergoing ADT. This was a randomized, double-blind, placebo-controlled, 12-week pilot study. Participants were randomly assigned to receive 20 g of soy protein containing 160 mg of total isoflavones vs taste-matched placebo (20 g whole milk protein). The study was conducted at a tertiary care center in the United States. Thirty-three men (isoflavones = 17, placebo = 16) undergoing ADT for PCa completed this pilot study. Mean age in the 2 groups was 69 years and the majority of men were Caucasians. Mean duration of ADT in both groups was approximately 2 years (P = .70). The 2 groups were well matched at baseline. After 12 weeks of intervention, there was no significant difference in either metabolic or inflammatory parameters between the 2 groups. We found that high-dose isoflavones over a course of 12 weeks do not improve metabolic or inflammatory parameters in androgen-deprived men.
authors.affiliation: National Institute of Health, National Institute on Aging, Laboratory of Clinical Investigation, Diabetes Section, Baltimore, Maryland, USA.
authors.forename: Joshua K
authors.initials: JK
authors.lastname: Napora
authors.forename: Ryan G
authors.initials: RG
authors.lastname: Short
authors.forename: Denis C
authors.initials: DC
authors.lastname: Muller
authors.forename: Olga D
authors.initials: OD
authors.lastname: Carlson
authors.forename: Juliana O
authors.initials: JO
authors.lastname: Odetunde
authors.forename: Xiaoqiang
authors.initials: X
authors.lastname: Xu
authors.forename: Michael
authors.initials: M
authors.lastname: Carducci
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Travison
authors.forename: Marcello
authors.initials: M
authors.lastname: Maggio
authors.forename: Josephine M
authors.initials: JM
authors.lastname: Egan
authors.forename: Shehzad
authors.initials: S
authors.lastname: Basaria
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000172:deficiency*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D007333:Insulin Resistance; D007529:Isoflavones / Q000008:administration & dosage*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010865:Pilot Projects; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D030262:Soybean Proteins / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D000728:Androgens; D007529:Isoflavones; D030262:Soybean Proteins; D005947:Glucose
references.citation: J Clin Endocrinol Metab. 2002 Jan;87(1):118-21
references.pmid: 11788633
references.citation: Phytother Res. 1999 Nov;13(7):601-8
references.pmid: 10548755
references.citation: Arch Intern Med. 1999 Sep 27;159(17):2070-6
references.pmid: 10510993
references.citation: Cancer. 2006 Feb 1;106(3):581-8
references.pmid: 16388523
references.citation: J Nutr. 2003 Sep;133(9):2874-8
references.pmid: 12949380
references.citation: Endocr Rev. 2002 Feb;23(1):90-119
references.pmid: 11844745
references.citation: J Biol Chem. 2003 Jan 10;278(2):962-7
references.pmid: 12421816
references.citation: J Clin Oncol. 2006 Aug 20;24(24):3979-83
references.pmid: 16921050
references.citation: Urology. 2000 Jan;55(1):97-101
references.pmid: 10654902
references.citation: J Nutr. 2001 Jun;131(6):1826-32
references.pmid: 11385074
references.citation: JAMA. 2005 Jul 13;294(2):238-44
references.pmid: 16014598
references.citation: J Immunol. 1999 Jul 1;163(1):374-9
references.pmid: 10384138
references.citation: J Clin Endocrinol Metab. 1999 Mar;84(3):895-8
references.pmid: 10084567
references.citation: Diabetes Res Clin Pract. 1991 Aug;13(1-2):119-29
references.pmid: 1773709
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2420-5
references.pmid: 17557956
references.citation: Clin Adv Hematol Oncol. 2006 Sep;4(9):687-96
references.pmid: 17099626
references.citation: Metabolism. 2008 Jul;57(7 Suppl 1):S24-31
references.pmid: 18555850
references.citation: Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86
references.pmid: 12072048
references.citation: Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S43-52
references.pmid: 7859632
references.citation: N Engl J Med. 1997 Jul 10;337(2):91-5
references.pmid: 9211678
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Nutr Cancer. 1999;33(1):82-7
references.pmid: 10227048
references.citation: J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24
references.pmid: 17925537
references.citation: Diabetes. 1994 Nov;43(11):1271-8
references.pmid: 7926300
references.citation: Am J Cardiol. 1990 Oct 15;66(12):921-5
references.pmid: 2220613
references.citation: Am J Clin Nutr. 2007 Mar;85(3):735-41
references.pmid: 17344494
references.citation: J Clin Endocrinol Metab. 2006 Jun;91(6):2209-13
references.pmid: 16595605
references.citation: Am J Clin Nutr. 2008 Jan;87(1):162-7
references.pmid: 18175751
references.citation: Menopause. 2009 Mar-Apr;16(2):395-400
references.pmid: 18981951
references.citation: J Immunol. 2001 Jul 1;167(1):542-52
references.pmid: 11418693
references.citation: Cancer Chemother Rep. 1975 Jan-Feb;59(1):225-7
references.pmid: 1093670
references.citation: N Engl J Med. 1997 Jul 31;337(5):295-300
references.pmid: 9233866
references.citation: Am J Clin Nutr. 2001 Apr;73(4):728-35
references.pmid: 11273847
references.citation: Endocrinology. 1998 Oct;139(10):4252-63
references.pmid: 9751507
references.citation: Cancer. 2007 Oct 1;110(7):1493-500
references.pmid: 17657815
references.citation: Curr Mol Med. 2005 May;5(3):333-9
references.pmid: 15892652
references.citation: Am J Cardiol. 2000 Jun 1;85(11):1297-301
references.pmid: 10831943
references.citation: J Clin Endocrinol Metab. 1998 Feb;83(2):297-303
references.pmid: 9467531
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: N Engl J Med. 1995 Aug 3;333(5):276-82
references.pmid: 7596371
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8):3068-75
references.pmid: 17682090
references.citation: Diabetes Care. 2004 May;27(5):1036-41
references.pmid: 15111517
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4448-56
references.pmid: 16983113
references.citation: J Clin Endocrinol Metab. 2005 Jul;90(7):3956-62
references.pmid: 15840745
references.citation: Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):247-54
references.pmid: 17940447
references.citation: J Clin Endocrinol Metab. 2008 Jan;93(1):68-75
references.pmid: 17911176
references.citation: Diabetes Care. 2002 Oct;25(10):1709-14
references.pmid: 12351466